Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706638 · ClinicalTrials.gov registry record · NA
Daily vs Intermittent Iron Therapy in Pregnancy
A NA study of Iron Deficiency Anemia of Pregnancy, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT03706638 is a NA study of Iron Deficiency Anemia of Pregnancy that has completed, run by UConn Health. The registered enrollment target is 46 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03706638, a NA study of Iron Deficiency Anemia of Pregnancy, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized non inferiority trial to evaluate the response to iron therapy in the standard daily vs. intermittent (three-four times a week on nonconsecutive days) groups by using hematological markers (hemoglobin, hematocrit, transferrin, hepcidin, ferritin, human soluble transferrin receptor). The secondary outcome is to evaluate gastrointestinal discomfort and adherence to therapy between two treatment groups.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ferrous Sulfate
Study Locations (1)
Connecticut
- UConn Health - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2020-03-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03706638
The ClinicalTrials.gov registry entry for NCT03706638 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Iron Deficiency Anemia of Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Ferrous Sulfate is the first listed.
NCT03706638 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT03706638 about?
NCT03706638 is a clinical study titled "Daily vs Intermittent Iron Therapy in Pregnancy". This is a randomized non inferiority trial to evaluate the response to iron therapy in the standard daily vs. intermittent (three-four times a week on nonconsecutive days) groups by using hematological markers (hemoglobin, hematocrit, transferrin, hepcidin, ferritin, human soluble transferrin recept...
What is the current status of trial NCT03706638?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-10-25. Estimated completion is 2020-03-23.
What conditions does trial NCT03706638 study?
This clinical trial studies the following conditions: Iron Deficiency Anemia of Pregnancy.
What interventions are being tested in trial NCT03706638?
The interventions under investigation include: Ferrous Sulfate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03706638?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03706638 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Iron Deficiency Anemia of Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.